orexigen therapeutics inc
(OREX:Consolidated Issue Listed on NASDAQ Global Select )
Mark D. Booth
|Age||Total Calculated Compensation||This person is connected to 19 board members in 2 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Mark D. Booth served as the Chief Commercial Officer of Orexigen Therapeutics, Inc. since August 2009 until March 2015. Mr. Booth served as President of Takeda Pharmaceuticals North America Inc. (TPNA) since August 2002 and also served as its Executive Vice President. He has over 25 years of commercial and business development experience. He held senior leadership positions in sales, operations and product development. Prior to joining TPNA, Mr. Booth served as General ...
3344 North Torrey Pines CourtPhone: 858-875-8600
La Jolla, California 92037
Board Members Memberships*
Northern Illinois University
J.L. Kellogg School of Management, Northwestern University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Marc N. Casper||Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee|
Thermo Fisher Scientific, Inc.
|Thomas P. Joyce Jr.||Chief Executive Officer, President, Director and Member of Finance Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Erez Vigodman||Chief Executive Officer, President, Director and Member of Finance & Invesment Committee|
Teva Pharmaceutical Industries Limited
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|3.1M GBP||Compensation as of Fiscal Year 2014.|